Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Natalie Bellini, CNP

Natalie Bellini, CNP

  • Specialty: Endocrinology
  • Location:
    UH Minoff Health Center
    3909 Orange Pl
    Beachwood, OH 44122

Biography: Natalie Bellini, CNP

Expertise

  • Diabetes

Certifications & Memberships

  • NP - Family - American Nurses Credentialing Center

Education

Professional Education
D'youville College (2021)

Professional Education
D'youville College (2018)

Undergraduate
Drexel University (2014)

About

Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES is an Endocrine Nurse Practitioner and Program Director of Technology at University Hospitals and Faculty Advisor for Close Concerns. Dr. Bellini earned her Bachelor's degree in Nursing from Drexel University and Family Nurse Practitioner and Doctor of Nursing Practice from D'Youville University. Dr. Bellini holds board certifications as a family nurse practitioner and in advanced diabetes management. She has published studies on topics including the use of GLP-1 agonists in patients with type 1 diabetes and using technology in diabetes management. She has been a speaker nationally and internationally regarding diabetes management and the impact of technology on diabetes care and outcomes.

As a faculty member for Close Concerns, Dr. Bellini works with the associates to bring perspective as a patient and a clinician to data and outcomes presented at conferences and earnings reports. She co-hosts podcast Diabetes Dialogue: Technology, Therapeutics, & Real Word Perspectives with colleague Dr. Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES.

Watch Natalie Bellini’s Health Talks

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Natalie Bellini did not disclose any Outside Relationships with Industry.